Global Human Granulocyte Colony-stimulating Factor Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Human Granulocyte Colony-stimulating Factor Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Human Granulocyte Colony-stimulating Factor by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Human Granulocyte Colony-stimulating Factor by Country/Region, 2017, 2022 & 2028

2.2 Human Granulocyte Colony-stimulating Factor Segment by Type

2.2.1 300μg/Dose

2.2.2 150μg/Dose

2.2.3 75μg/Dose

2.2.4 Others

2.3 Human Granulocyte Colony-stimulating Factor Sales by Type

2.3.1 Global Human Granulocyte Colony-stimulating Factor Sales Market Share by Type (2017-2022)

2.3.2 Global Human Granulocyte Colony-stimulating Factor Revenue and Market Share by Type (2017-2022)

2.3.3 Global Human Granulocyte Colony-stimulating Factor Sale Price by Type (2017-2022)

2.4 Human Granulocyte Colony-stimulating Factor Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.5 Human Granulocyte Colony-stimulating Factor Sales by Application

2.5.1 Global Human Granulocyte Colony-stimulating Factor Sale Market Share by Application (2017-2022)

2.5.2 Global Human Granulocyte Colony-stimulating Factor Revenue and Market Share by Application (2017-2022)

2.5.3 Global Human Granulocyte Colony-stimulating Factor Sale Price by Application (2017-2022)

3 Global Human Granulocyte Colony-stimulating Factor by Company

3.1 Global Human Granulocyte Colony-stimulating Factor Breakdown Data by Company

3.1.1 Global Human Granulocyte Colony-stimulating Factor Annual Sales by Company (2020-2022)

3.1.2 Global Human Granulocyte Colony-stimulating Factor Sales Market Share by Company (2020-2022)

3.2 Global Human Granulocyte Colony-stimulating Factor Annual Revenue by Company (2020-2022)

3.2.1 Global Human Granulocyte Colony-stimulating Factor Revenue by Company (2020-2022)

3.2.2 Global Human Granulocyte Colony-stimulating Factor Revenue Market Share by Company (2020-2022)

3.3 Global Human Granulocyte Colony-stimulating Factor Sale Price by Company

3.4 Key Manufacturers Human Granulocyte Colony-stimulating Factor Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Human Granulocyte Colony-stimulating Factor Product Location Distribution

3.4.2 Players Human Granulocyte Colony-stimulating Factor Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Human Granulocyte Colony-stimulating Factor by Geographic Region

4.1 World Historic Human Granulocyte Colony-stimulating Factor Market Size by Geographic Region (2017-2022)

4.1.1 Global Human Granulocyte Colony-stimulating Factor Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Human Granulocyte Colony-stimulating Factor Annual Revenue by Geographic Region

4.2 World Historic Human Granulocyte Colony-stimulating Factor Market Size by Country/Region (2017-2022)

4.2.1 Global Human Granulocyte Colony-stimulating Factor Annual Sales by Country/Region (2017-2022)

4.2.2 Global Human Granulocyte Colony-stimulating Factor Annual Revenue by Country/Region

4.3 Americas Human Granulocyte Colony-stimulating Factor Sales Growth

4.4 APAC Human Granulocyte Colony-stimulating Factor Sales Growth

4.5 Europe Human Granulocyte Colony-stimulating Factor Sales Growth

4.6 Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales Growth

5 Americas

5.1 Americas Human Granulocyte Colony-stimulating Factor Sales by Country

5.1.1 Americas Human Granulocyte Colony-stimulating Factor Sales by Country (2017-2022)

5.1.2 Americas Human Granulocyte Colony-stimulating Factor Revenue by Country (2017-2022)

5.2 Americas Human Granulocyte Colony-stimulating Factor Sales by Type

5.3 Americas Human Granulocyte Colony-stimulating Factor Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Human Granulocyte Colony-stimulating Factor Sales by Region

6.1.1 APAC Human Granulocyte Colony-stimulating Factor Sales by Region (2017-2022)

6.1.2 APAC Human Granulocyte Colony-stimulating Factor Revenue by Region (2017-2022)

6.2 APAC Human Granulocyte Colony-stimulating Factor Sales by Type

6.3 APAC Human Granulocyte Colony-stimulating Factor Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Human Granulocyte Colony-stimulating Factor by Country

7.1.1 Europe Human Granulocyte Colony-stimulating Factor Sales by Country (2017-2022)

7.1.2 Europe Human Granulocyte Colony-stimulating Factor Revenue by Country (2017-2022)

7.2 Europe Human Granulocyte Colony-stimulating Factor Sales by Type

7.3 Europe Human Granulocyte Colony-stimulating Factor Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Human Granulocyte Colony-stimulating Factor by Country

8.1.1 Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales by Country (2017-2022)

8.1.2 Middle East & Africa Human Granulocyte Colony-stimulating Factor Revenue by Country (2017-2022)

8.2 Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales by Type

8.3 Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Human Granulocyte Colony-stimulating Factor

10.3 Manufacturing Process Analysis of Human Granulocyte Colony-stimulating Factor

10.4 Industry Chain Structure of Human Granulocyte Colony-stimulating Factor

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Human Granulocyte Colony-stimulating Factor Distributors

11.3 Human Granulocyte Colony-stimulating Factor Customer

12 World Forecast Review for Human Granulocyte Colony-stimulating Factor by Geographic Region

12.1 Global Human Granulocyte Colony-stimulating Factor Market Size Forecast by Region

12.1.1 Global Human Granulocyte Colony-stimulating Factor Forecast by Region (2023-2028)

12.1.2 Global Human Granulocyte Colony-stimulating Factor Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Human Granulocyte Colony-stimulating Factor Forecast by Type

12.7 Global Human Granulocyte Colony-stimulating Factor Forecast by Application

13 Key Players Analysis

13.1 Chugai Pharmaceutical

13.1.1 Chugai Pharmaceutical Company Information

13.1.2 Chugai Pharmaceutical Human Granulocyte Colony-stimulating Factor Product Offered

13.1.3 Chugai Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Chugai Pharmaceutical Main Business Overview

13.1.5 Chugai Pharmaceutical Latest Developments

13.2 Kyowa Hakko Kirin

13.2.1 Kyowa Hakko Kirin Company Information

13.2.2 Kyowa Hakko Kirin Human Granulocyte Colony-stimulating Factor Product Offered

13.2.3 Kyowa Hakko Kirin Human Granulocyte Colony-stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Kyowa Hakko Kirin Main Business Overview

13.2.5 Kyowa Hakko Kirin Latest Developments

13.3 Sanway

13.3.1 Sanway Company Information

13.3.2 Sanway Human Granulocyte Colony-stimulating Factor Product Offered

13.3.3 Sanway Human Granulocyte Colony-stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Sanway Main Business Overview

13.3.5 Sanway Latest Developments

13.4 GenSci

13.4.1 GenSci Company Information

13.4.2 GenSci Human Granulocyte Colony-stimulating Factor Product Offered

13.4.3 GenSci Human Granulocyte Colony-stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 GenSci Main Business Overview

13.4.5 GenSci Latest Developments

13.5 SL PHARM

13.5.1 SL PHARM Company Information

13.5.2 SL PHARM Human Granulocyte Colony-stimulating Factor Product Offered

13.5.3 SL PHARM Human Granulocyte Colony-stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 SL PHARM Main Business Overview

13.5.5 SL PHARM Latest Developments

13.6 Kexing Bioproducts

13.6.1 Kexing Bioproducts Company Information

13.6.2 Kexing Bioproducts Human Granulocyte Colony-stimulating Factor Product Offered

13.6.3 Kexing Bioproducts Human Granulocyte Colony-stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Kexing Bioproducts Main Business Overview

13.6.5 Kexing Bioproducts Latest Developments

13.7 Qilu Pharmaceutical

13.7.1 Qilu Pharmaceutical Company Information

13.7.2 Qilu Pharmaceutical Human Granulocyte Colony-stimulating Factor Product Offered

13.7.3 Qilu Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Qilu Pharmaceutical Main Business Overview

13.7.5 Qilu Pharmaceutical Latest Developments

13.8 CSPC

13.8.1 CSPC Company Information

13.8.2 CSPC Human Granulocyte Colony-stimulating Factor Product Offered

13.8.3 CSPC Human Granulocyte Colony-stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 CSPC Main Business Overview

13.8.5 CSPC Latest Developments

13.9 Wuzhong Pharmaceutical

13.9.1 Wuzhong Pharmaceutical Company Information

13.9.2 Wuzhong Pharmaceutical Human Granulocyte Colony-stimulating Factor Product Offered

13.9.3 Wuzhong Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Wuzhong Pharmaceutical Main Business Overview

13.9.5 Wuzhong Pharmaceutical Latest Developments

13.10 Quangang Pharmaceutical

13.10.1 Quangang Pharmaceutical Company Information

13.10.2 Quangang Pharmaceutical Human Granulocyte Colony-stimulating Factor Product Offered

13.10.3 Quangang Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Quangang Pharmaceutical Main Business Overview

13.10.5 Quangang Pharmaceutical Latest Developments

13.11 Huabei Pharmaceutical

13.11.1 Huabei Pharmaceutical Company Information

13.11.2 Huabei Pharmaceutical Human Granulocyte Colony-stimulating Factor Product Offered

13.11.3 Huabei Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Huabei Pharmaceutical Main Business Overview

13.11.5 Huabei Pharmaceutical Latest Developments

13.12 Harbin Pharmaceutical

13.12.1 Harbin Pharmaceutical Company Information

13.12.2 Harbin Pharmaceutical Human Granulocyte Colony-stimulating Factor Product Offered

13.12.3 Harbin Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Harbin Pharmaceutical Main Business Overview

13.12.5 Harbin Pharmaceutical Latest Developments

13.13 Amoytop Biotech

13.13.1 Amoytop Biotech Company Information

13.13.2 Amoytop Biotech Human Granulocyte Colony-stimulating Factor Product Offered

13.13.3 Amoytop Biotech Human Granulocyte Colony-stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Amoytop Biotech Main Business Overview

13.13.5 Amoytop Biotech Latest Developments

13.14 Jiuyuan Gene Engineering

13.14.1 Jiuyuan Gene Engineering Company Information

13.14.2 Jiuyuan Gene Engineering Human Granulocyte Colony-stimulating Factor Product Offered

13.14.3 Jiuyuan Gene Engineering Human Granulocyte Colony-stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Jiuyuan Gene Engineering Main Business Overview

13.14.5 Jiuyuan Gene Engineering Latest Developments

13.15 Four Rings Biopharmaceutical

13.15.1 Four Rings Biopharmaceutical Company Information

13.15.2 Four Rings Biopharmaceutical Human Granulocyte Colony-stimulating Factor Product Offered

13.15.3 Four Rings Biopharmaceutical Human Granulocyte Colony-stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Four Rings Biopharmaceutical Main Business Overview

13.15.5 Four Rings Biopharmaceutical Latest Developments

14 Research Findings and Conclusion

Table 1. Human Granulocyte Colony-stimulating Factor Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Human Granulocyte Colony-stimulating Factor Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 300μg/Dose

Table 4. Major Players of 150μg/Dose

Table 5. Major Players of 75μg/Dose

Table 6. Major Players of Others

Table 7. Global Human Granulocyte Colony-stimulating Factor Sales by Type (2017-2022) & (K Units)

Table 8. Global Human Granulocyte Colony-stimulating Factor Sales Market Share by Type (2017-2022)

Table 9. Global Human Granulocyte Colony-stimulating Factor Revenue by Type (2017-2022) & ($ million)

Table 10. Global Human Granulocyte Colony-stimulating Factor Revenue Market Share by Type (2017-2022)

Table 11. Global Human Granulocyte Colony-stimulating Factor Sale Price by Type (2017-2022) & (US$/Unit)

Table 12. Global Human Granulocyte Colony-stimulating Factor Sales by Application (2017-2022) & (K Units)

Table 13. Global Human Granulocyte Colony-stimulating Factor Sales Market Share by Application (2017-2022)

Table 14. Global Human Granulocyte Colony-stimulating Factor Revenue by Application (2017-2022)

Table 15. Global Human Granulocyte Colony-stimulating Factor Revenue Market Share by Application (2017-2022)

Table 16. Global Human Granulocyte Colony-stimulating Factor Sale Price by Application (2017-2022) & (US$/Unit)

Table 17. Global Human Granulocyte Colony-stimulating Factor Sales by Company (2020-2022) & (K Units)

Table 18. Global Human Granulocyte Colony-stimulating Factor Sales Market Share by Company (2020-2022)

Table 19. Global Human Granulocyte Colony-stimulating Factor Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Human Granulocyte Colony-stimulating Factor Revenue Market Share by Company (2020-2022)

Table 21. Global Human Granulocyte Colony-stimulating Factor Sale Price by Company (2020-2022) & (US$/Unit)

Table 22. Key Manufacturers Human Granulocyte Colony-stimulating Factor Producing Area Distribution and Sales Area

Table 23. Players Human Granulocyte Colony-stimulating Factor Products Offered

Table 24. Human Granulocyte Colony-stimulating Factor Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Human Granulocyte Colony-stimulating Factor Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Human Granulocyte Colony-stimulating Factor Sales Market Share Geographic Region (2017-2022)

Table 29. Global Human Granulocyte Colony-stimulating Factor Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Human Granulocyte Colony-stimulating Factor Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Human Granulocyte Colony-stimulating Factor Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Human Granulocyte Colony-stimulating Factor Sales Market Share by Country/Region (2017-2022)

Table 33. Global Human Granulocyte Colony-stimulating Factor Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Human Granulocyte Colony-stimulating Factor Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Human Granulocyte Colony-stimulating Factor Sales by Country (2017-2022) & (K Units)

Table 36. Americas Human Granulocyte Colony-stimulating Factor Sales Market Share by Country (2017-2022)

Table 37. Americas Human Granulocyte Colony-stimulating Factor Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Human Granulocyte Colony-stimulating Factor Revenue Market Share by Country (2017-2022)

Table 39. Americas Human Granulocyte Colony-stimulating Factor Sales by Type (2017-2022) & (K Units)

Table 40. Americas Human Granulocyte Colony-stimulating Factor Sales Market Share by Type (2017-2022)

Table 41. Americas Human Granulocyte Colony-stimulating Factor Sales by Application (2017-2022) & (K Units)

Table 42. Americas Human Granulocyte Colony-stimulating Factor Sales Market Share by Application (2017-2022)

Table 43. APAC Human Granulocyte Colony-stimulating Factor Sales by Region (2017-2022) & (K Units)

Table 44. APAC Human Granulocyte Colony-stimulating Factor Sales Market Share by Region (2017-2022)

Table 45. APAC Human Granulocyte Colony-stimulating Factor Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Human Granulocyte Colony-stimulating Factor Revenue Market Share by Region (2017-2022)

Table 47. APAC Human Granulocyte Colony-stimulating Factor Sales by Type (2017-2022) & (K Units)

Table 48. APAC Human Granulocyte Colony-stimulating Factor Sales Market Share by Type (2017-2022)

Table 49. APAC Human Granulocyte Colony-stimulating Factor Sales by Application (2017-2022) & (K Units)

Table 50. APAC Human Granulocyte Colony-stimulating Factor Sales Market Share by Application (2017-2022)

Table 51. Europe Human Granulocyte Colony-stimulating Factor Sales by Country (2017-2022) & (K Units)

Table 52. Europe Human Granulocyte Colony-stimulating Factor Sales Market Share by Country (2017-2022)

Table 53. Europe Human Granulocyte Colony-stimulating Factor Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Human Granulocyte Colony-stimulating Factor Revenue Market Share by Country (2017-2022)

Table 55. Europe Human Granulocyte Colony-stimulating Factor Sales by Type (2017-2022) & (K Units)

Table 56. Europe Human Granulocyte Colony-stimulating Factor Sales Market Share by Type (2017-2022)

Table 57. Europe Human Granulocyte Colony-stimulating Factor Sales by Application (2017-2022) & (K Units)

Table 58. Europe Human Granulocyte Colony-stimulating Factor Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Human Granulocyte Colony-stimulating Factor Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Human Granulocyte Colony-stimulating Factor Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Human Granulocyte Colony-stimulating Factor

Table 68. Key Market Challenges & Risks of Human Granulocyte Colony-stimulating Factor

Table 69. Key Industry Trends of Human Granulocyte Colony-stimulating Factor

Table 70. Human Granulocyte Colony-stimulating Factor Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Human Granulocyte Colony-stimulating Factor Distributors List

Table 73. Human Granulocyte Colony-stimulating Factor Customer List

Table 74. Global Human Granulocyte Colony-stimulating Factor Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Human Granulocyte Colony-stimulating Factor Sales Market Forecast by Region

Table 76. Global Human Granulocyte Colony-stimulating Factor Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Human Granulocyte Colony-stimulating Factor Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Human Granulocyte Colony-stimulating Factor Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Human Granulocyte Colony-stimulating Factor Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Human Granulocyte Colony-stimulating Factor Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Human Granulocyte Colony-stimulating Factor Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Human Granulocyte Colony-stimulating Factor Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Human Granulocyte Colony-stimulating Factor Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Human Granulocyte Colony-stimulating Factor Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Human Granulocyte Colony-stimulating Factor Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Human Granulocyte Colony-stimulating Factor Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Human Granulocyte Colony-stimulating Factor Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Human Granulocyte Colony-stimulating Factor Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Human Granulocyte Colony-stimulating Factor Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Human Granulocyte Colony-stimulating Factor Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Human Granulocyte Colony-stimulating Factor Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Human Granulocyte Colony-stimulating Factor Revenue Market Share Forecast by Application (2023-2028)

Table 94. Chugai Pharmaceutical Basic Information, Human Granulocyte Colony-stimulating Factor Manufacturing Base, Sales Area and Its Competitors

Table 95. Chugai Pharmaceutical Human Granulocyte Colony-stimulating Factor Product Offered

Table 96. Chugai Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 97. Chugai Pharmaceutical Main Business

Table 98. Chugai Pharmaceutical Latest Developments

Table 99. Kyowa Hakko Kirin Basic Information, Human Granulocyte Colony-stimulating Factor Manufacturing Base, Sales Area and Its Competitors

Table 100. Kyowa Hakko Kirin Human Granulocyte Colony-stimulating Factor Product Offered

Table 101. Kyowa Hakko Kirin Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 102. Kyowa Hakko Kirin Main Business

Table 103. Kyowa Hakko Kirin Latest Developments

Table 104. Sanway Basic Information, Human Granulocyte Colony-stimulating Factor Manufacturing Base, Sales Area and Its Competitors

Table 105. Sanway Human Granulocyte Colony-stimulating Factor Product Offered

Table 106. Sanway Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 107. Sanway Main Business

Table 108. Sanway Latest Developments

Table 109. GenSci Basic Information, Human Granulocyte Colony-stimulating Factor Manufacturing Base, Sales Area and Its Competitors

Table 110. GenSci Human Granulocyte Colony-stimulating Factor Product Offered

Table 111. GenSci Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 112. GenSci Main Business

Table 113. GenSci Latest Developments

Table 114. SL PHARM Basic Information, Human Granulocyte Colony-stimulating Factor Manufacturing Base, Sales Area and Its Competitors

Table 115. SL PHARM Human Granulocyte Colony-stimulating Factor Product Offered

Table 116. SL PHARM Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 117. SL PHARM Main Business

Table 118. SL PHARM Latest Developments

Table 119. Kexing Bioproducts Basic Information, Human Granulocyte Colony-stimulating Factor Manufacturing Base, Sales Area and Its Competitors

Table 120. Kexing Bioproducts Human Granulocyte Colony-stimulating Factor Product Offered

Table 121. Kexing Bioproducts Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 122. Kexing Bioproducts Main Business

Table 123. Kexing Bioproducts Latest Developments

Table 124. Qilu Pharmaceutical Basic Information, Human Granulocyte Colony-stimulating Factor Manufacturing Base, Sales Area and Its Competitors

Table 125. Qilu Pharmaceutical Human Granulocyte Colony-stimulating Factor Product Offered

Table 126. Qilu Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 127. Qilu Pharmaceutical Main Business

Table 128. Qilu Pharmaceutical Latest Developments

Table 129. CSPC Basic Information, Human Granulocyte Colony-stimulating Factor Manufacturing Base, Sales Area and Its Competitors

Table 130. CSPC Human Granulocyte Colony-stimulating Factor Product Offered

Table 131. CSPC Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 132. CSPC Main Business

Table 133. CSPC Latest Developments

Table 134. Wuzhong Pharmaceutical Basic Information, Human Granulocyte Colony-stimulating Factor Manufacturing Base, Sales Area and Its Competitors

Table 135. Wuzhong Pharmaceutical Human Granulocyte Colony-stimulating Factor Product Offered

Table 136. Wuzhong Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 137. Wuzhong Pharmaceutical Main Business

Table 138. Wuzhong Pharmaceutical Latest Developments

Table 139. Quangang Pharmaceutical Basic Information, Human Granulocyte Colony-stimulating Factor Manufacturing Base, Sales Area and Its Competitors

Table 140. Quangang Pharmaceutical Human Granulocyte Colony-stimulating Factor Product Offered

Table 141. Quangang Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 142. Quangang Pharmaceutical Main Business

Table 143. Quangang Pharmaceutical Latest Developments

Table 144. Huabei Pharmaceutical Basic Information, Human Granulocyte Colony-stimulating Factor Manufacturing Base, Sales Area and Its Competitors

Table 145. Huabei Pharmaceutical Human Granulocyte Colony-stimulating Factor Product Offered

Table 146. Huabei Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 147. Huabei Pharmaceutical Main Business

Table 148. Huabei Pharmaceutical Latest Developments

Table 149. Harbin Pharmaceutical Basic Information, Human Granulocyte Colony-stimulating Factor Manufacturing Base, Sales Area and Its Competitors

Table 150. Harbin Pharmaceutical Human Granulocyte Colony-stimulating Factor Product Offered

Table 151. Harbin Pharmaceutical Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 152. Harbin Pharmaceutical Main Business

Table 153. Harbin Pharmaceutical Latest Developments

Table 154. Amoytop Biotech Basic Information, Human Granulocyte Colony-stimulating Factor Manufacturing Base, Sales Area and Its Competitors

Table 155. Amoytop Biotech Human Granulocyte Colony-stimulating Factor Product Offered

Table 156. Amoytop Biotech Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 157. Amoytop Biotech Main Business

Table 158. Amoytop Biotech Latest Developments

Table 159. Jiuyuan Gene Engineering Basic Information, Human Granulocyte Colony-stimulating Factor Manufacturing Base, Sales Area and Its Competitors

Table 160. Jiuyuan Gene Engineering Human Granulocyte Colony-stimulating Factor Product Offered

Table 161. Jiuyuan Gene Engineering Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 162. Jiuyuan Gene Engineering Main Business

Table 163. Jiuyuan Gene Engineering Latest Developments

Table 164. Four Rings Biopharmaceutical Basic Information, Human Granulocyte Colony-stimulating Factor Manufacturing Base, Sales Area and Its Competitors

Table 165. Four Rings Biopharmaceutical Human Granulocyte Colony-stimulating Factor Product Offered

Table 166. Four Rings Biopharmaceutical Human Granulocyte Colony-stimulating Factor Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 167. Four Rings Biopharmaceutical Main Business

Table 168. Four Rings Biopharmaceutical Latest Developments

List of Figures

Figure 1. Picture of Human Granulocyte Colony-stimulating Factor

Figure 2. Human Granulocyte Colony-stimulating Factor Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Human Granulocyte Colony-stimulating Factor Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Human Granulocyte Colony-stimulating Factor Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Human Granulocyte Colony-stimulating Factor Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 300μg/Dose

Figure 10. Product Picture of 150μg/Dose

Figure 11. Product Picture of 75μg/Dose

Figure 12. Product Picture of Others

Figure 13. Global Human Granulocyte Colony-stimulating Factor Sales Market Share by Type in 2021

Figure 14. Global Human Granulocyte Colony-stimulating Factor Revenue Market Share by Type (2017-2022)

Figure 15. Human Granulocyte Colony-stimulating Factor Consumed in Hospital

Figure 16. Global Human Granulocyte Colony-stimulating Factor Market: Hospital (2017-2022) & (K Units)

Figure 17. Human Granulocyte Colony-stimulating Factor Consumed in Clinic

Figure 18. Global Human Granulocyte Colony-stimulating Factor Market: Clinic (2017-2022) & (K Units)

Figure 19. Global Human Granulocyte Colony-stimulating Factor Sales Market Share by Application (2017-2022)

Figure 20. Global Human Granulocyte Colony-stimulating Factor Revenue Market Share by Application in 2021

Figure 21. Human Granulocyte Colony-stimulating Factor Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Human Granulocyte Colony-stimulating Factor Revenue Market Share by Company in 2021

Figure 23. Global Human Granulocyte Colony-stimulating Factor Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Human Granulocyte Colony-stimulating Factor Revenue Market Share by Geographic Region in 2021

Figure 25. Global Human Granulocyte Colony-stimulating Factor Sales Market Share by Region (2017-2022)

Figure 26. Global Human Granulocyte Colony-stimulating Factor Revenue Market Share by Country/Region in 2021

Figure 27. Americas Human Granulocyte Colony-stimulating Factor Sales 2017-2022 (K Units)

Figure 28. Americas Human Granulocyte Colony-stimulating Factor Revenue 2017-2022 ($ Millions)

Figure 29. APAC Human Granulocyte Colony-stimulating Factor Sales 2017-2022 (K Units)

Figure 30. APAC Human Granulocyte Colony-stimulating Factor Revenue 2017-2022 ($ Millions)

Figure 31. Europe Human Granulocyte Colony-stimulating Factor Sales 2017-2022 (K Units)

Figure 32. Europe Human Granulocyte Colony-stimulating Factor Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales 2017-2022 (K Units)

Figure 34. Middle East & Africa Human Granulocyte Colony-stimulating Factor Revenue 2017-2022 ($ Millions)

Figure 35. Americas Human Granulocyte Colony-stimulating Factor Sales Market Share by Country in 2021

Figure 36. Americas Human Granulocyte Colony-stimulating Factor Revenue Market Share by Country in 2021

Figure 37. United States Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Human Granulocyte Colony-stimulating Factor Sales Market Share by Region in 2021

Figure 42. APAC Human Granulocyte Colony-stimulating Factor Revenue Market Share by Regions in 2021

Figure 43. China Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Human Granulocyte Colony-stimulating Factor Sales Market Share by Country in 2021

Figure 50. Europe Human Granulocyte Colony-stimulating Factor Revenue Market Share by Country in 2021

Figure 51. Germany Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Human Granulocyte Colony-stimulating Factor Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Human Granulocyte Colony-stimulating Factor Revenue Market Share by Country in 2021

Figure 58. Egypt Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Human Granulocyte Colony-stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Human Granulocyte Colony-stimulating Factor in 2021

Figure 64. Manufacturing Process Analysis of Human Granulocyte Colony-stimulating Factor

Figure 65. Industry Chain Structure of Human Granulocyte Colony-stimulating Factor

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles